Abstract
In Europe, in the epidemic season 2017, the incidence of West Nile fever did not exceed the index of the previous season. In the US and Canada, there was an increase in the incidence of cases. West Nile fever morbidity rates in the Russian Federation and in separate constituent entities were below the average long-term index and had the lowest value for the period since 2008. 41.6 % of WNF cases were imported to Russia from the distant countries. Analysis of the monitoring results indicated the circulation of WNF virus markers in carriers of the pathogen in 6 constituent entities of the Russian Federation, and the presence of IgG antibodies in healthy population cohorts in 24 RF entities. According to molecular-genetic typing of WNF virus samples from mosquito Culex modestus from the Volgograd Region, WNF virus genotype II was established. Forecasting of epidemiological situation development for the year 2018 does not rule out the possibility of local increase in WNF incidence in certain regions of Russia.
Highlights
На территории стран-членов Европейского Союза в эпидемический сезон 2017 г. заболеваемость населения лихорадкой Западного Нила (ЛЗН) не превышала показателей прошлого сезона
Volgograd Research Anti-Plague Institute of the Rospotrebnadzor, Volgograd, Russian Federation In Europe, in the epidemic season 2017, the incidence of West Nile fever did not exceed the index of the previous season
West Nile fever morbidity rates in the Russian Federation and in separate constituent entities were below the average long-term index and had the lowest value for the period since 2008. 41.6 % of WNF cases were imported to Russia from the distant countries
Summary
На территории стран-членов Европейского Союза в эпидемический сезон 2017 г. заболеваемость населения лихорадкой Западного Нила (ЛЗН) не превышала показателей прошлого сезона. Удельный вес (долевое распределение) случаев ЛЗН, зарегистрированных в США, Канаде, Российской Федерации и странах Европейского Союза в сезон 2017 г.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.